sgb 1534 has been researched along with terazosin in 1 studies
Studies (sgb 1534) | Trials (sgb 1534) | Recent Studies (post-2010) (sgb 1534) | Studies (terazosin) | Trials (terazosin) | Recent Studies (post-2010) (terazosin) |
---|---|---|---|---|---|
20 | 0 | 0 | 658 | 173 | 104 |
Protein | Taxonomy | sgb 1534 (IC50) | terazosin (IC50) |
---|---|---|---|
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.428 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 6.042 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.011 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.005 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.005 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagatomo, T; Tsuchihashi, H | 1 |
1 other study(ies) available for sgb 1534 and terazosin
Article | Year |
---|---|
Alpha-blocking potencies of antihypertensive agents (prazosin, terazosin, bunazosin, SGB-1534 and ketanserin) having with quinazoline or quinazolinedione as assessed by radioligand binding assay methods in rat brain.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Brain; Cell Membrane; Clonidine; Dihydroalprenolol; Ketanserin; Male; Prazosin; Quinazolines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1989 |